Clinical studies showing efficacy of lactobacilli for treatment of cancer
| Bacteria | Dose | Pathology | Ref. (Design) |
|---|---|---|---|
| B. lactis Bb12 L. rhamnosus GG + Oligofructose enriched inulin (SYN1) | 1×1010 CFU (total) 12 g | Colon cancer | 39(randomised, double-blind, placebo-controlled study) |
| L. rhamnosus LC705 P. freudenreichii subsp Shermanii | 2–5×1010 CFU (of each) | Liver cancer | 78(randomised, double-blind, placebo-controlled study) |
| B. longum L. acidophilus E. faecalis | 108 CFU/g (0.21 g) (total) | Colorectal cancer | 79(open study) |
| B. natto L. acidophilus | 10 mg 30 mg | Colorectal cancer | 80(open study) |